323 related articles for article (PubMed ID: 15491469)
1. Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection.
Perch M; Kofoed P; Fischer TK; Có F; Rombo L; Aaby P; Eugen-Olsen J
Parasite Immunol; 2004 May; 26(5):207-11. PubMed ID: 15491469
[TBL] [Abstract][Full Text] [Related]
2. Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome.
Ostrowski SR; Ullum H; Goka BQ; Høyer-Hansen G; Obeng-Adjei G; Pedersen BK; Akanmori BD; Kurtzhals JA
J Infect Dis; 2005 Apr; 191(8):1331-41. PubMed ID: 15776381
[TBL] [Abstract][Full Text] [Related]
3. Elevated plasma urokinase receptor predicts low birth weight in maternal malaria.
Ostrowski SR; Shulman CE; Peshu N; Staalsøe T; Høyer-Hansen G; Pedersen BK; Marsh K; Ullum H
Parasite Immunol; 2007 Jan; 29(1):37-46. PubMed ID: 17187653
[TBL] [Abstract][Full Text] [Related]
4. The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau.
Eugen-Olsen J; Gustafson P; Sidenius N; Fischer TK; Parner J; Aaby P; Gomes VF; Lisse I
Int J Tuberc Lung Dis; 2002 Aug; 6(8):686-92. PubMed ID: 12150480
[TBL] [Abstract][Full Text] [Related]
5. Relationship between antipyretic effects and cytokine levels in uncomplicated falciparum malaria during different treatment regimes.
Hugosson E; Montgomery SM; Premji Z; Troye-Blomberg M; Björkman A
Acta Trop; 2006 Aug; 99(1):75-82. PubMed ID: 16962547
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) levels in stage III ovarian cancer patients.
Begum FD; Høgdall CK; Kjaer SK; Christensen L; Blaakaer J; Bock JE; Glud E; Høyer-Hansen G; Ring-Larsen H; Høgdall EV
Anticancer Res; 2004; 24(3b):1981-5. PubMed ID: 15274388
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer.
Riisbro R; Christensen IJ; Piironen T; Greenall M; Larsen B; Stephens RW; Han C; Høyer-Hansen G; Smith K; Brünner N; Harris AL
Clin Cancer Res; 2002 May; 8(5):1132-41. PubMed ID: 12006529
[TBL] [Abstract][Full Text] [Related]
8. Higher IL-10 levels are associated with less effective clearance of Plasmodium falciparum parasites.
Hugosson E; Montgomery SM; Premji Z; Troye-Blomberg M; Björkman A
Parasite Immunol; 2004 Mar; 26(3):111-7. PubMed ID: 15279621
[TBL] [Abstract][Full Text] [Related]
9. Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial.
Boggild AK; Krudsood S; Patel SN; Serghides L; Tangpukdee N; Katz K; Wilairatana P; Liles WC; Looareesuwan S; Kain KC
Clin Infect Dis; 2009 Sep; 49(6):841-9. PubMed ID: 19673614
[TBL] [Abstract][Full Text] [Related]
10. The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality.
Wittenhagen P; Kronborg G; Weis N; Nielsen H; Obel N; Pedersen SS; Eugen-Olsen J
Clin Microbiol Infect; 2004 May; 10(5):409-15. PubMed ID: 15113317
[TBL] [Abstract][Full Text] [Related]
11. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
[TBL] [Abstract][Full Text] [Related]
12. Serum complement levels in asymptomatic Plasmodium falciparum parasitaemic children.
Umotong AB; Amanor-Boadu SD; Okerengwo AA; Hedo CC
Trop Geogr Med; 1994; 46(3):134-7. PubMed ID: 7941000
[TBL] [Abstract][Full Text] [Related]
13. Mefloquine treatment for uncomplicated falciparum malaria in young children 6-24 months of age in northern Ghana.
Fryauff DJ; Owusu-Agyei S; Utz G; Baird JK; Koram KA; Binka F; Nkrumah F; Hoffman SL
Am J Trop Med Hyg; 2007 Feb; 76(2):224-31. PubMed ID: 17297028
[TBL] [Abstract][Full Text] [Related]
14. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
[TBL] [Abstract][Full Text] [Related]
15. Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2007; 119(4):475-80. PubMed ID: 16828495
[TBL] [Abstract][Full Text] [Related]
16. Effect of Plasmodium falciparum malaria on plasma fibrinopeptide-A (FpA) concentration.
Jimmy EO; Saliu I; Okpala I; Walker O; Sowumni A; Ademowo OG; Essien EM
Cent Afr J Med; 1995 Apr; 41(4):124-7. PubMed ID: 7788683
[TBL] [Abstract][Full Text] [Related]
17. Reduced release of intact and cleaved urokinase receptor in stimulated whole-blood cultures from human immunodeficiency virus-1-infected patients.
Ostrowski SR; Piironen T; Høyer-Hansen G; Gerstoft J; Pedersen BK; Ullum H
Scand J Immunol; 2005 Apr; 61(4):347-56. PubMed ID: 15853918
[TBL] [Abstract][Full Text] [Related]
18. Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy.
Mustjoki S; Sidenius N; Sier CF; Blasi F; Elonen E; Alitalo R; Vaheri A
Cancer Res; 2000 Dec; 60(24):7126-32. PubMed ID: 11156421
[TBL] [Abstract][Full Text] [Related]
19. Soluble urokinase plasminogen activator receptor in blood transfusion components.
Riisbro R; Brünner N; Christensen IJ; Nielsen HJ
Transfus Med; 2004 Aug; 14(4):305-12. PubMed ID: 15285727
[TBL] [Abstract][Full Text] [Related]
20. Persistent fever in severe malaria in children.
Commey J; Quarm-Goka B; Agyepong I
Cent Afr J Med; 1994 Sep; 40(9):257-60. PubMed ID: 7834716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
